Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive disease, marked by
excessive scarring, which leads to increased tissue stiffness, loss in lung function and …

Idiopathic pulmonary fibrosis (IPF) is the prototypic progressive fibrotic interstitial lung
disease. Median survival is only 3 years, and treatment options are limited. IPF is thought to …

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an appalling
prognosis. The failure of anti-inflammatory therapies coupled with the observation that …

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic disease of the lung that is marked by
progressive decline in pulmonary function and ultimately respiratory failure. Genetic and …

Pulmonary fibrosis is characterised by excessive scarring in the lung which leads to
compromised lung function, serious breathing problems and in some diseases, death. It …

Aim This study explored the cellular and biological interrelationships involved in Idiopathic
Pulmonary Fibrosis (IPF) lung tissue remodelling using immunohistochemical analysis …

Idiopathic pulmonary fibrosis (IPF) is a serious disease of the lung, which leads to extensive
parenchymal scarring and death from respiratory failure. The most accepted hypothesis for …

IPF (idiopathic pulmonary fibrosis) is a chronic progressive disease of unknown aetiology
without effective treatment. IPF is characterized by excessive collagen deposition within the …

Many lung diseases result in fibrotic remodelling. Fibrotic lung disorders can be divided into
diseases with known and unknown aetiology. Among those with unknown aetiology …

Idiopathic pulmonary fibrosis (IPF) is the most frequent fibrotic diffuse parenchymal lung
disease. Its prognosis is devastating:> 50% of the patients die within 3 years after diagnosis …